首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages
【2h】

Effect of osteoprotegerin and osteoprotegerin ligand on osteoclast formation by arthroplasty membrane derived macrophages

机译:骨保护素和骨保护素配体对关节置换膜衍生巨噬细胞对破骨细胞形成的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

OBJECTIVE—Osteoprotegerin ligand (OPGL) is a newly discovered molecule, which is expressed by osteoblasts/bone stromal cells. This ligand and M-CSF are now known to be essential for osteoclast differentiation from marrow and circulating precursors. This study examined whether OPGL and its soluble receptor osteoprotegerin (OPG), influenced osteoclast formation from human arthroplasty derived macrophages, to determine if the effects of OPGL and OPG on these cells could contribute to the osteolysis of aseptic loosening.
METHODS—OPGL (± dexamethasone/M-CSF) was added to cultures of macrophages isolated from the pseudomembrane of loosened hip arthroplasties incubated on glass coverslips and dentine slices. OPG was added to cocultures of arthroplasty derived macrophages and UMR106 osteoblast-like cells. Osteoclast differentiation in long term cultures was assessed by expression of macrophage (CD14) and osteoclast markers (tartrate resistant acid phosphatase (TRAP), vitronectin receptor (VNR) and lacunar resorption).
RESULTS—In the absence of osteoblastic cells, the addition of OPGL alone was sufficient to induce differentiation of macrophages (CD14+, TRAP-, VNR-) into TRAP+ and VNR+ multinucleated cells, capable of extensive lacunar resorption. OPG was found to inhibit osteoclast formation by arthroplasty macrophages in a dose dependent manner. OPG (100 ng/ml) more than halved the formation of TRAP+ and VNR+ cells and the extent of lacunar resorption in co-cultures of UMR106 cells and arthroplasty macrophages.
CONCLUSIONS—This study has shown that macrophages, isolated from the pseudomembrane surrounding loose arthroplasty components, are capable of differentiating into osteoclastic bone resorbing cells and that OPGL is required for this to occur. OPG inhibits this process, most probably by interrupting the cell-cell interaction between osteoblasts and mononuclear phagocyte osteoclast precursors present in the pseudomembrane.

机译:目的—骨桥蛋白配体(OPGL)是一个新发现的分子,由成骨细胞/骨基质细胞表达。现在已知该配体和M-CSF对于破骨细胞与骨髓和循环前体的分化至关重要。这项研究检查了OPGL及其可溶性受体骨保护素(OPG)是否影响了来自人工关节成形术衍生的巨噬细胞的破骨细胞形成,以确定OPGL和OPG对这些细胞的作用是否有助于无菌性松动的骨溶解。
方法:将OPGL(±地塞米松/ M-CSF)添加到巨噬细胞培养物中,该巨噬细胞是从在玻璃盖玻片和牙本质切片上孵育的松动髋关节置换假膜中分离出来的。 OPG被添加到关节成形术衍生的巨噬细胞和UMR106成骨细胞样细胞的共培养物中。长期培养中的破骨细胞分化通过巨噬细胞(CD14)和破骨细胞标志物(酒石酸盐抗性酸性磷酸酶(TRAP),玻连蛋白受体(VNR)和腔隙吸收)的表达来评估。
结果-在没有成骨细胞的情况下,单独添加OPGL足以诱导巨噬细胞(CD14 + ,TRAP -,VNR -)分化为TRAP + < / sup>和VNR + 多核细胞,能够广泛吸收腔隙。发现OPG通过关节成形术巨噬细胞以剂量依赖性方式抑制破骨细胞形成。 OPG(100ng / ml)将UMR106细胞和人工关节巨噬细胞共培养的TRAP + 和VNR + 细胞的形成和腔隙吸收的程度减少了一半以上。
结论—这项研究表明,巨噬细胞是从周围松散的关节置换部件周围的假膜中分离出来的,能够分化为破骨细胞骨吸收细胞,而OPGL是必需的。 OPG可能通过中断成骨细胞和假膜中存在的单核吞噬细胞破骨细胞前体之间的细胞间相互作用来抑制该过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号